The Virtus Terranova U.S. Quality Momentum ETF (JOET) has consistently underperformed compared to the benchmark IVV since early 2020, with a negative active return of -3.99% from December 2020 to April 2026. Despite its focus on stocks with strong profitability ratings and high return on equity, its inability to provide growth-at-a-reasonable-price (GARP) exposure and disappointing performance have led the analyst to maintain a Hold rating. This ongoing underperformance questions the effectiveness of JOET's combined momentum and quality investment approach in generating alpha for investors.
Ultragenyx Pharmaceutical Inc. awarded 44,409 restricted stock units to 15 newly hired non-executive officers under its Employment Inducement Plan. The grants, approved by the compensation committee, vest over four years with 25% vesting annually, co...
Nyxoah has announced an extraordinary general meeting of shareholders set for July 9, 2026, at its headquarters in Belgium. The meeting will discuss renewing the authorization for the board to increase the company's capital over the next five years, ...
Eupraxia Pharmaceuticals held its Annual General Meeting on June 18, 2026, where shareholders elected all seven board nominees proposed by management with strong majority votes. Additionally, KPMG LLP was reappointed as the company's auditor for the ...
Cate & Chloe is discounting its Bianca 18k Gold-Plated Crystal Hoop Earrings to $19.98 from $86 during Amazon Prime Day 2026, running June 23-26. This 77% markdown aligns with growing consumer demand for affordable luxury jewelry, with earrings price...
Rua Gold Inc. announced the filing of a Preliminary Economic Assessment (PEA) for its Auld Creek Gold Antimony Project in New Zealand's Reefton Goldfield. The PEA includes updated mineral resource estimates and economic analysis considering new geote...
